-
ASCH Proteins and N4-Acetylcytidine Processing
2026-09-30
Meng et al. define how the ASCH-domain protein EcYqfB hydrolyzes free N4-acetylcytidine while showing that it does not remove ac4C from RNA. Comparative structures of EcYqfB, mouse EOLA1, and the human TRIP4-ASCH domain clarify how related proteins can differ in substrate preference, informing nucleotide processing assays and RNA modification studies.
-
Palmitic acid (N2456): Protocol and QC
2026-09-30
Palmitic acid (SKU N2456), also called hexadecanoic acid, provides a characterized saturated long-chain fatty acid input for lipid and metabolic research. This guide covers non-aqueous preparation, solvent selection, QC, and storage while clarifying that the material is water-insoluble and prepared solutions are not intended for long-term storage.
-
Ferritin Hybrid Particles for Combination Vaccines
2026-09-29
The reference study develops an Escherichia coli-produced ferritin hybrid particle that co-displays influenza A M2e and SARS-CoV-2 spike-protein tandem epitopes. In mice, the hybrid particle generated stronger antigen-specific responses than antigen-only controls and showed functional activity in pseudovirus inhibition, cell-surface binding, and ADCC assays.
-
Sex Differences in Angiotensin II Hypertension
2026-09-29
Xue, Pamidimukkala, and Hay showed that chronic angiotensin II produced substantially greater hypertension in conscious male mice than in female mice, while gonadectomy reversed much of this sex pattern. Telemetry, baroreflex testing, and ganglionic blockade linked the blood-pressure difference to altered autonomic regulation rather than to baseline pressure alone.
-
Intravesical p21 mRNA-LNP for Bladder Cancer
2026-09-28
The study evaluates lipid nanoparticles carrying chemically modified p21 mRNA as a localized tumor-suppressor replacement strategy for bladder cancer. In cell and mouse models, intravesical delivery restored p21 expression and suppressed tumor growth, while the reported evidence remains preclinical and does not establish clinical efficacy.
-
Z-VDVAD-FMK: Practical Apoptosis Assay Design
2026-09-27
Learn how to use Z-VDVAD-FMK (SKU A1922) to investigate caspase-2-associated apoptosis, interpret mitochondrial and cell-death readouts, and manage compound handling. This scenario-led guide distinguishes supported product information from experimental recommendations and explains when caspase-1-driven pyroptosis requires a different approach.
-
L-Alanyl-L-Glutamine: Practical Workflow Guide
2026-09-26
L-Alanyl-L-glutamine provides a water-soluble dipeptide option for aqueous nutritional and intestinal barrier research workflows. It is unsuitable for DMSO- or ethanol-based formulations, and prepared solutions are not recommended for long-term storage.
-
CMA Decline Drives Age-Related Skeletal Muscle Myopathy
2026-09-26
This study shows that chaperone-mediated autophagy (CMA) supports skeletal muscle integrity, and that its age-related decline is associated with progressive muscle dysfunction. Using mouse models, proteomic analysis and human muscle samples, the researchers connect CMA loss to altered SERCA turnover and calcium handling, while finding that genetic CMA upregulation partially improves age-related muscle phenotypes.
-
Gemini QACs: Broad-Spectrum Biocidal Design
2026-09-25
A 2024 study synthesized 16 octenidine-derived gemini quaternary ammonium compounds and compared their antimicrobial activity, cytotoxicity, and predicted membrane permeation. The results identify distinct antibacterial, antifungal, and virucidal leads—notably compounds 1 and 12—while illustrating why activity, selectivity, and solubility must be evaluated together.
-
SmD2 Acetylation Links Splicing to PARP Sensitivity
2026-09-25
A 2024 study connects acetylation-dependent control of the spliceosome protein SmD2 with BRCA1/FANC cassette-exon processing, DNA damage responses, and PARP-inhibitor sensitivity in hepatocellular carcinoma. Its preclinical findings support testing HDAC inhibition with PARP inhibition in HCC models, while leaving clinical efficacy and optimal treatment parameters unresolved.
-
ZIF-8 Nanotheranostics for TNBC: Key Findings
2026-09-24
Li et al. report a folic acid- and PEG-functionalized ZIF-8 platform carrying ciprofloxacin that combines ultrasound imaging with sonodynamic, chemotherapeutic, and immune effects in triple-negative breast cancer models. The findings support further preclinical study of this integrated approach, while the available report does not provide enough protocol detail to reproduce its ultrasound exposure or dosing conditions.
-
USP42 Suppresses JNK/p38 Apoptosis in Breast Cancer
2026-09-24
A 2025 study links elevated USP42 expression with breast cancer stage and shows that USP42 knockdown reduces cell growth while increasing apoptosis alongside JNK and p38 phosphorylation. The findings support a role for USP42 in restraining stress-kinase-associated apoptosis, while leaving its direct molecular substrates and clinical relevance for further study.
-
TMB for Precision P. vivax Serology
2026-09-23
TMB is more than a routine chromogenic reagent: it is the signal-conversion layer that can translate defined Plasmodium vivax epitope recognition into a scalable serological decision. This article connects TMB chemistry with epitope discovery, assay controls, multiplex validation, and the translational requirements for detecting hidden malaria reservoirs.
-
Gallein B7271: Reliable GPCR Assay Workflows
2026-09-23
This scenario-based guide explains how Gallein (SKU B7271) can support reproducible studies of G protein βγ signaling while avoiding common misinterpretations in viability, proliferation, and cytotoxicity assays. It combines product-backed handling parameters with practical controls for cancer, immunology, and cardiometabolic models.
-
Protease Inhibitor Cocktail for Signaling Workflows
2026-09-22
Protect fragile signaling proteins during cell, tissue, and brain lysate preparation with an EDTA-free, 100X formulation designed for phosphorylation-sensitive workflows. This guide connects protease control to PF4/Pcdhg/Pyk2 research, co-immunoprecipitation, Western blotting, kinase assays, and practical troubleshooting.